143 related articles for article (PubMed ID: 14551009)
1. Human immunodeficiency virus retesting during pregnancy: costs and effectiveness in preventing perinatal transmission.
Sansom SL; Jamieson DJ; Farnham PG; Bulterys M; Fowler MG
Obstet Gynecol; 2003 Oct; 102(4):782-90. PubMed ID: 14551009
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago.
Immergluck LC; Cull WL; Schwartz A; Elstein AS
Pediatrics; 2000 Apr; 105(4):E54. PubMed ID: 10742375
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting.
Mansergh G; Haddix AC; Steketee RW; Nieburg PI; Hu DJ; Simonds RJ; Rogers M
JAMA; 1996 Jul; 276(2):139-45. PubMed ID: 8656506
[TBL] [Abstract][Full Text] [Related]
4. Preventing perinatal transmission of HIV--costs and effectiveness of a recommended intervention.
Gorsky RD; Farnham PG; Straus WL; Caldwell B; Holtgrave DR; Simonds RJ; Rogers MF; Guinan ME
Public Health Rep; 1996; 111(4):335-41. PubMed ID: 8711101
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of strategies to reduce mother-to-child HIV transmission in Mexico, a low-prevalence setting.
Rely K; Bertozzi SM; Avila-Figueroa C; Guijarro MT
Health Policy Plan; 2003 Sep; 18(3):290-8. PubMed ID: 12917270
[TBL] [Abstract][Full Text] [Related]
6. Universal antenatal human immunodeficiency virus (HIV) testing programme is cost-effective despite a low HIV prevalence in Hong Kong.
Lee PM; Wong KH
Hong Kong Med J; 2007 Jun; 13(3):199-207. PubMed ID: 17548908
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of interventions to reduce vertical HIV transmission from pregnant women who have not received prenatal care.
Mrus JM; Tsevat J
Med Decis Making; 2004; 24(1):30-9. PubMed ID: 15005952
[TBL] [Abstract][Full Text] [Related]
8. The cost-effectiveness of repeat HIV testing during pregnancy in a resource-limited setting.
Kim LH; Cohan DL; Sparks TN; Pilliod RA; Arinaitwe E; Caughey AB
J Acquir Immune Defic Syndr; 2013 Jun; 63(2):195-200. PubMed ID: 23392461
[TBL] [Abstract][Full Text] [Related]
9. Perinatal HIV transmission and the cost-effectiveness of screening at 14 weeks gestation, at the onset of labour and the rapid testing of infants.
Udeh B; Udeh C; Graves N
BMC Infect Dis; 2008 Dec; 8():174. PubMed ID: 19117527
[TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of HIV screening in pregnant women attending antenatal clinics in India.
Kumar M; Birch S; Maturana A; Gafni A
Health Policy; 2006 Jul; 77(2):233-43. PubMed ID: 16126300
[TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness of voluntary intrapartum rapid human immunodeficiency virus testing for women without adequate prenatal care.
Grobman WA; Garcia PM
Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 1):1062-71. PubMed ID: 10561619
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of HIV and syphilis antenatal screening: a modelling study.
Bristow CC; Larson E; Anderson LJ; Klausner JD
Sex Transm Infect; 2016 Aug; 92(5):340-6. PubMed ID: 26920867
[TBL] [Abstract][Full Text] [Related]
13. [A comparison of three screening strategies for prevention of perinatal HIV infection in Colombia: a decision analysis model].
Gómez M
Rev Panam Salud Publica; 2008 Oct; 24(4):256-64. PubMed ID: 19133174
[TBL] [Abstract][Full Text] [Related]
14. Missed Opportunities for Repeat HIV Testing in Pregnancy: Implications for Elimination of Mother-to-Child Transmission in the United States.
Liao C; Golden WC; Anderson JR; Coleman JS
AIDS Patient Care STDS; 2017 Jan; 31(1):20-26. PubMed ID: 27936863
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission in eight African countries.
Sweat MD; O'Reilly KR; Schmid GP; Denison J; de Zoysa I
AIDS; 2004 Aug; 18(12):1661-71. PubMed ID: 15280777
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of elective cesarean delivery in human immunodeficiency virus-infected women(1).
Chen KT; Sell RL; Tuomala RE
Obstet Gynecol; 2001 Feb; 97(2):161-8. PubMed ID: 11165575
[TBL] [Abstract][Full Text] [Related]
17. The impact of initiating a human immunodeficiency virus screening program in an urban obstetric population.
Lewis R; O'Brien JM; Ray DT; Sibai BM
Am J Obstet Gynecol; 1995 Oct; 173(4):1329-33. PubMed ID: 7485348
[TBL] [Abstract][Full Text] [Related]
18. Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine. Implications for HIV screening.
Mauskopf JA; Paul JE; Wichman DS; White AD; Tilson HH
JAMA; 1996 Jul; 276(2):132-8. PubMed ID: 8656505
[TBL] [Abstract][Full Text] [Related]
19. Benefits of HIV screening of blood transfusions in Zambia.
Foster S; Buvé A
Lancet; 1995 Jul; 346(8969):225-7. PubMed ID: 7616804
[TBL] [Abstract][Full Text] [Related]
20. The cost effectiveness of universal antenatal screening for HIV in New Zealand.
Bramley D; Graves N; Walker D
AIDS; 2003 Mar; 17(5):741-8. PubMed ID: 12646798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
